Bone and joint involvement in Fabry disease

作者: K Sacre , O Lidove , B Giroux Leprieur , N Ouali , J Laganier

DOI: 10.3109/03009740903270631

关键词:

摘要: Fabry disease (FD) is an X-linked lysosomal storage caused by deficient activity of the enzyme alpha-galactosidase A. Although has progressive effects on most organ systems in body, data limited regarding skeletal involvement this rare disorder. We describe four family-related patients, three men and one premenopausal female, sharing a classic phenotype FD. Dual-energy X-ray was performed all cases osteoporosis or osteopenia were found patients osteoporotic fractures one. One patient also showed both neuropathic joint osteonecrosis. Several mechanisms that may explain osteoarthropathy setting FD are emphasized.

参考文章(12)
Peter R. Ebeling, Osteoporosis in Men New England Journal of Medicine. ,vol. 358, pp. 1474- 1482 ,(2008) , 10.1056/NEJMCP0707217
Henriette Mersebach, Jan-Ove Johansson, åse krogh Rasmussen, Bengt-Åke Bengtsson, Kirsten Rosenberg, Lis Hasholt, Sven Asger Sørensen, Søren schwartz Sørensen, Ulla Feldt-Rasmussen, Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density Genetics in Medicine. ,vol. 9, pp. 812- 818 ,(2007) , 10.1097/GIM.0B013E31815CB197
G. Farhat, B. Yamout, M. A. Mikati, S. Demirjian, R. Sawaya, G. El-Hajj Fuleihan, Effect of antiepileptic drugs on bone density in ambulatory patients Neurology. ,vol. 58, pp. 1348- 1353 ,(2002) , 10.1212/WNL.58.9.1348
Roscoe O. Brady, Andrew E. Gal, Roy M. Bradley, Erik Martensson, Andrew L. Warshaw, Leonard Laster, Enzymatic Defect in Fabry's Disease New England Journal of Medicine. ,vol. 276, pp. 1163- 1167 ,(1967) , 10.1056/NEJM196705252762101
Maryam Banikazemi, Thomas Ullman, Robert. J. Desnick, Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy. Molecular Genetics and Metabolism. ,vol. 85, pp. 255- 259 ,(2005) , 10.1016/J.YMGME.2005.04.009
Gregory M. Pastores, Sylvan Wallenstein, Robert J. Desnick, Marjorie M. Luckey, Bone density in Type 1 Gaucher disease. Journal of Bone and Mineral Research. ,vol. 11, pp. 1801- 1807 ,(2009) , 10.1002/JBMR.5650111125
Robert J Desnick, Roscoe Brady, John Barranger, Allan J Collins, Dominique P Germain, Martin Goldman, Gregory Grabowski, Seymour Packman, William R Wilcox, Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Annals of Internal Medicine. ,vol. 138, pp. 338- 346 ,(2003) , 10.7326/0003-4819-138-4-200302180-00014
Edward M. Kaye, Edwin H. Kolodny, Eric L. Logigian, M. David Ullman, Nervous system involvement in Fabry's disease: Clinicopathological and biochemical correlation Annals of Neurology. ,vol. 23, pp. 505- 509 ,(1988) , 10.1002/ANA.410230513